Aurobindo Pharma balance sheet

·Pharma & HealthChart ›
As of Mar 2026
Total assets
₹58,502cr+17.5% on Mar 2025
Shareholders' equity
₹37,883cr+16.0% on Mar 2025
Total debt
₹7,676cr−3.3% on Mar 2025
Cash and investments
₹7,939cr+42.6% on Mar 2025
₹ crore except per share
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Non-current assets
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
14,33012,18911,5467,995
3,0093,2662,7394,496
800618595596
2,2771,9872,3522,432
2,2051,6341,129894
10945.594.890.0
195206227302
7.66.75.85.6
0.01080.00.0
550538351150
753859584458
1,4841,2931,213677
828731613705
25,79322,62320,86618,344
Current assets
12,05310,5449,8088,511
7470.050.6151
7,0945,7464,8174,466
7,1915,5693,3934,396
2,6792,6672,8851,688
17.915.612.912.4
101262263290
17,83114,25911,42211,004
2,8032,3572,5361,954
32,70927,16223,77221,546
0.00.04340.0
58,50249,78545,07239,890
Equity
58.158.158.658.6
37,83332,59529,78426,781
37,89132,65329,84326,840
−8.2−6.48.012.0
37,88332,64729,85126,852
Liabilities
8031,5622,135619
535253268334
1,3381,8152,403953
400283226173
306303357390
53654.536.529.0
2,5802,4563,0221,544
6,8736,3804,1804,243
5,5674,1894,4543,871
4,4083,0062,1811,825
16,84913,57510,8169,938
353276257201
211285249212
6265478771,143
18,03914,68212,19911,494
20,61917,13815,22113,038
58,50249,78545,07239,890
Assets — additional as-filed lines
21.72.85.775.6
Trade payables — MSME split
19286.2——
5,3754,103——
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

AUROPHARMA₹1,644.80

Aurobindo Pharma Ltd.

· Pharma & Health
₹ CrorePeersSUNPHARMADRREDDYCIPLAFORTISLUPINALKEMLAURUSLABSMANKINDMcap ₹95,530 Cr
View
In ₹ Crore except Per Share
As of
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment7,995.411,545.512,189.414,329.914,329.9
+ Capital Work-in-Progress4,496.42,739.43,266.03,008.83,008.8
+ Goodwill596.1595.2618.0800.2800.2
+ Other Intangibles2,432.22,352.11,986.72,276.52,276.5
+ Intangibles under Development893.61,129.31,634.02,204.72,204.7
+ Investments (Equity Method)90.094.845.5108.8108.8
+ Non-current Investments301.7226.9206.2195.0195.0
+ Long-term Loans5.65.86.77.67.6
+ Trade Receivables — Non-current0.00.0108.30.00.0
+ Other Non-current Financial Assets150.4351.0537.7549.9549.9
Non-current Financial Assets457.7583.7858.9752.5752.5
+ Deferred Tax Assets677.51,212.61,293.01,483.61,483.6
+ Other Non-current Assets705.5613.3730.9828.3828.3
Total Non-current Assets18,344.320,865.922,622.525,793.425,793.4
Current Assets
+ Inventories8,511.29,808.210,543.712,052.912,052.9
+ Current Investments151.050.60.0747.2747.2
+ Trade Receivables4,466.44,816.75,745.97,094.47,094.4
+ Cash & Cash Equivalents4,396.33,393.55,569.07,191.47,191.4
+ Other Bank Balances1,687.92,884.82,666.52,678.92,678.9
+ Short-term Loans12.412.915.617.917.9
+ Other Current Financial Assets290.4263.1262.0101.0101.0
Current Financial Assets11,004.411,421.614,258.917,830.717,830.7
+ Other Current Assets1,954.52,536.42,357.02,803.42,803.4
Total Current Assets21,545.723,771.927,162.532,708.832,708.8
+ Assets Held for Sale0.0433.70.00.00.0
Total Assets39,890.045,071.549,785.058,502.258,502.2
Equity
+ Equity Share Capital58.658.658.158.158.1
+ Other Equity / Reserves26,781.329,784.232,595.237,832.937,832.9
Equity — Owners of Parent26,839.929,842.832,653.337,891.037,891.0
+ Minority Interest12.08.0-6.4-8.2-8.2
Total Equity26,851.929,850.832,646.937,882.837,882.8
Liabilities
+ Borrowings — Non-current619.02,134.91,561.7802.8802.8
+ Other Non-current Financial Liab334.0268.0253.3534.8534.8
Non-current Financial Liabilities953.02,402.91,815.01,337.61,337.6
+ Provisions — Non-current172.7225.7282.9400.4400.4
+ Deferred Tax Liabilities389.6356.6303.3306.0306.0
+ Other Non-current Liabilities29.036.554.5536.4536.4
Non-current Liabilities1,544.43,021.62,455.72,580.32,580.3
+ Borrowings — Current4,242.64,180.36,380.06,873.56,873.5
+ Trade Payables3,871.34,454.24,188.95,567.35,567.3
+ Other Current Financial Liab1,824.52,181.53,006.14,408.44,408.4
Current Financial Liabilities9,938.410,816.013,575.016,849.116,849.1
+ Provisions — Current200.5256.8275.6353.0353.0
+ Current Tax Liabilities211.6249.0284.9210.6210.6
+ Other Current Liabilities1,143.3877.4546.8626.3626.3
Current Liabilities11,493.812,199.114,682.318,039.018,039.0
Total Liabilities13,038.115,220.717,138.020,619.320,619.3
Total Equity & Liabilities39,890.045,071.549,785.058,502.258,502.2
Assets — additional as-filed lines
+ Current Tax Assets75.65.72.821.721.7
Trade Payables — MSME split
+ Dues to Micro & Small — Current——86.2191.9191.9
+ Dues to Other Creditors — Current——4,102.65,375.45,375.4
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.